Company
A4M is a Seattle based, physician led, artificial intelligence (AI) company, building algorithms and clinical decision support tools for medicine’s triple aim: Access, Quality, & Cost.
Product
The CDST is a SaaS application.
Six-month minimum contract, volume related per member per month fee.
This includes a 6- hour training seminar with case studies on how to better manage HTN and how to optimize the CDST. P4P guarantee- if we cannot improve your rate of control over baseline all fees are refunded.
The A4M program uses peak diurnal home BP monitoring to better classify hypertension excluding white coat HTN (20-30%) and detecting masked HTN (20%). Missing masked HTN will affect your present baseline rate of control. We aim to exceed the Healthy People 2020 control rate goal of 62% with less provider time, improving access and quality while reducing cost. Projected ROI is > 20:1 based on the AHA estimated cardiovascular cost savings of $1,048 per controlled hypertensive/year. The application also provides performance monitoring, comparing rates of control, disease distribution, relative drug costs, time management and outcomes among providers and across delivery systems. Data useful in HEDIS reporting.